A1 adenosine receptor activation increases adipocyte leptin secretion

被引:39
作者
Rice, AM
Fain, JN
Rivkees, SA
机构
[1] Yale Univ, Sch Med, Dept Pediat, Sect Pediat Endocrinol, New Haven, CT 06520 USA
[2] Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA
关键词
D O I
10.1210/en.141.4.1442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A1 adenosine receptors (AIARs) are heavily expressed in adipocytes and influence fat cell metabolism. Because increasing evidence suggests a role for leptin in mediating appetite and fat cell metabolism, we tested whether A1ARs regulate leptin production. Rats were treated with the A1AR agonist N-6-cyclopentyladenosine (CPA), and changes in circulating levels of leptin and leptin gene expression were examined. Serum leptin levels rose 2- to 10-fold, with peak increases seen 8-16 h after injection of CPA (P < 0.05). In contrast, CPA did not alter steady state levels of adipose tissue leptin mRNA. To assess the influence of endogenous adenosine on circulating leptin levels, rats were also injected with dipyridamole (DPY), an adenosine reuptake blocker. DPY induced 80% increases in serum levels at 8 h alter injections (P < 0.05). Supporting the idea that stimulation of leptin production isA1AR mediated, pretreatment with the A1AR antagonist 8-cyclopentyl-1,3-dipropylxanthine completely blocked increases in leptin levels after DPY treatment. To complement in vivo studies, the effect of A1AR activation on leptin secretion was also studied in epididymal fat pad cultures. In cultures, CPA treatment increased leptin secretion by 37% (P < 0.05). Collectively, these data show that the adenosinergic system can increase leptin secretion by directly activating A1ARs in fat tissue.
引用
收藏
页码:1442 / 1445
页数:4
相关论文
共 49 条
  • [1] Effects of repeated administration of selective adenosine A(1) and A(2A) receptor agonists on pentylenetetrazole-induced convulsions in the rat
    Adami, M
    Bertorelli, R
    Ferri, N
    Foddi, MC
    Ongini, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) : 383 - 389
  • [2] MODELING OF THE PHARMACODYNAMIC INTERACTION OF AN A(1) ADENOSINE RECEPTOR AGONIST AND ANTAGONIST IN-VIVO - N-6-CYCLOPENTYLADENOSINE AND 8-CYCLOPENTYLTHEOPHYLLINE
    APPEL, S
    MATHOT, RAA
    LANGEMIJER, MWE
    IJZERMAN, AP
    DANHOF, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) : 1253 - 1259
  • [3] AUSUBEL FM, 1999, ANAL RNA NO SLOT BLO, P21
  • [4] Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes
    Bradley, RL
    Cheatham, B
    [J]. DIABETES, 1999, 48 (02) : 272 - 278
  • [5] Leptin and clinical medicine: A new piece in the puzzle of obesity
    Bray, GA
    York, DA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) : 2771 - 2776
  • [6] RECOMBINANT MOUSE OB PROTEIN - EVIDENCE FOR A PERIPHERAL SIGNAL LINKING ADIPOSITY AND CENTRAL NEURAL NETWORKS
    CAMPFIELD, LA
    SMITH, FJ
    GUISEZ, Y
    DEVOS, R
    BURN, P
    [J]. SCIENCE, 1995, 269 (5223) : 546 - 549
  • [7] Chen DL, 1999, J LIPID RES, V40, P1735
  • [8] Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
    Chen, H
    Charlat, O
    Tartaglia, LA
    Woolf, EA
    Weng, X
    Ellis, SJ
    Lakey, ND
    Culpepper, J
    Moore, KJ
    Breitbart, RE
    Duyk, GM
    Tepper, RI
    Morgenstern, JP
    [J]. CELL, 1996, 84 (03) : 491 - 495
  • [9] CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
  • [10] A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
    Clément, K
    Vaisse, C
    Lahlou, N
    Cabrol, S
    Pelloux, V
    Cassuto, D
    Gourmelen, M
    Dina, C
    Chambaz, J
    Lacorte, JM
    Basdevant, A
    Bougneres, P
    Lebouc, Y
    Froguel, P
    Guy-Grand, B
    [J]. NATURE, 1998, 392 (6674) : 398 - 401